nodes	percent_of_prediction	percent_of_DWPC	metapath
Propranolol—hypertension—type 2 diabetes mellitus	0.357	1	CtDrD
Propranolol—ADRB3—type 2 diabetes mellitus	0.16	0.657	CbGaD
Propranolol—CYP1A2—type 2 diabetes mellitus	0.0504	0.207	CbGaD
Propranolol—CYP3A4—type 2 diabetes mellitus	0.0334	0.137	CbGaD
Propranolol—ORM1—Nateglinide—type 2 diabetes mellitus	0.0212	0.0802	CbGbCtD
Propranolol—HTR1B—Bromocriptine—type 2 diabetes mellitus	0.02	0.0757	CbGbCtD
Propranolol—ADRB1—Bromocriptine—type 2 diabetes mellitus	0.0156	0.0592	CbGbCtD
Propranolol—HTR1A—Bromocriptine—type 2 diabetes mellitus	0.0125	0.0474	CbGbCtD
Propranolol—CYP3A7-CYP3A51P—Nateglinide—type 2 diabetes mellitus	0.00953	0.0362	CbGbCtD
Propranolol—CYP3A7—Nateglinide—type 2 diabetes mellitus	0.00953	0.0362	CbGbCtD
Propranolol—ABCB1—Linagliptin—type 2 diabetes mellitus	0.00953	0.0361	CbGbCtD
Propranolol—CYP2C19—Gliclazide—type 2 diabetes mellitus	0.00895	0.0339	CbGbCtD
Propranolol—ABCB1—Sitagliptin—type 2 diabetes mellitus	0.0085	0.0322	CbGbCtD
Propranolol—CYP2C19—Pioglitazone—type 2 diabetes mellitus	0.00761	0.0289	CbGbCtD
Propranolol—CYP2C19—Chlorpropamide—type 2 diabetes mellitus	0.00761	0.0289	CbGbCtD
Propranolol—SLC22A2—Metformin—type 2 diabetes mellitus	0.00716	0.0271	CbGbCtD
Propranolol—CYP3A5—Nateglinide—type 2 diabetes mellitus	0.00715	0.0271	CbGbCtD
Propranolol—CYP2C19—Rosiglitazone—type 2 diabetes mellitus	0.00703	0.0266	CbGbCtD
Propranolol—CYP2C19—Tolbutamide—type 2 diabetes mellitus	0.00678	0.0257	CbGbCtD
Propranolol—CYP1A2—Rosiglitazone—type 2 diabetes mellitus	0.00648	0.0246	CbGbCtD
Propranolol—ABCB1—Chlorpropamide—type 2 diabetes mellitus	0.00614	0.0233	CbGbCtD
Propranolol—CYP2D6—Pioglitazone—type 2 diabetes mellitus	0.00579	0.0219	CbGbCtD
Propranolol—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.00571	0.0217	CbGbCtD
Propranolol—CYP2D6—Rosiglitazone—type 2 diabetes mellitus	0.00534	0.0203	CbGbCtD
Propranolol—CYP1A2—Irbesartan—type 2 diabetes mellitus	0.0051	0.0194	CbGbCtD
Propranolol—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.00509	0.0193	CbGbCtD
Propranolol—CYP1A2—Bromocriptine—type 2 diabetes mellitus	0.00483	0.0183	CbGbCtD
Propranolol—CYP3A4—Glipizide—type 2 diabetes mellitus	0.00466	0.0177	CbGbCtD
Propranolol—CYP3A5—Losartan—type 2 diabetes mellitus	0.00442	0.0168	CbGbCtD
Propranolol—CYP2D6—Nateglinide—type 2 diabetes mellitus	0.00439	0.0166	CbGbCtD
Propranolol—ABCB1—Bromocriptine—type 2 diabetes mellitus	0.00422	0.016	CbGbCtD
Propranolol—CYP2D6—Irbesartan—type 2 diabetes mellitus	0.0042	0.0159	CbGbCtD
Propranolol—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.00407	0.0154	CbGbCtD
Propranolol—CYP2C19—Glyburide—type 2 diabetes mellitus	0.0039	0.0148	CbGbCtD
Propranolol—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.00368	0.014	CbGbCtD
Propranolol—CYP2C19—Losartan—type 2 diabetes mellitus	0.00356	0.0135	CbGbCtD
Propranolol—CYP1A2—Losartan—type 2 diabetes mellitus	0.00329	0.0125	CbGbCtD
Propranolol—ADRB3—brown adipose tissue—type 2 diabetes mellitus	0.00326	0.342	CbGeAlD
Propranolol—ABCB1—Glyburide—type 2 diabetes mellitus	0.00314	0.0119	CbGbCtD
Propranolol—ABCB1—Losartan—type 2 diabetes mellitus	0.00288	0.0109	CbGbCtD
Propranolol—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.00279	0.0106	CbGbCtD
Propranolol—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.00267	0.0101	CbGbCtD
Propranolol—CYP3A4—Orlistat—type 2 diabetes mellitus	0.00267	0.0101	CbGbCtD
Propranolol—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.00253	0.00959	CbGbCtD
Propranolol—CYP3A4—Glyburide—type 2 diabetes mellitus	0.00188	0.00714	CbGbCtD
Propranolol—CYP3A4—Losartan—type 2 diabetes mellitus	0.00172	0.00653	CbGbCtD
Propranolol—HTR1B—artery—type 2 diabetes mellitus	0.000624	0.0654	CbGeAlD
Propranolol—ADRB3—adipose tissue—type 2 diabetes mellitus	0.00044	0.0461	CbGeAlD
Propranolol—CYP3A7-CYP3A51P—nephron tubule—type 2 diabetes mellitus	0.000346	0.0363	CbGeAlD
Propranolol—SLC22A2—nephron tubule—type 2 diabetes mellitus	0.000334	0.035	CbGeAlD
Propranolol—CYP3A7-CYP3A51P—cortex of kidney—type 2 diabetes mellitus	0.000296	0.031	CbGeAlD
Propranolol—SLC22A2—kidney—type 2 diabetes mellitus	0.000293	0.0308	CbGeAlD
Propranolol—SLC22A2—cortex of kidney—type 2 diabetes mellitus	0.000286	0.03	CbGeAlD
Propranolol—Carvedilol—NPPB—type 2 diabetes mellitus	0.000243	0.0984	CrCbGaD
Propranolol—Carvedilol—GJA1—type 2 diabetes mellitus	0.000243	0.0984	CrCbGaD
Propranolol—CYP3A7—liver—type 2 diabetes mellitus	0.000226	0.0237	CbGeAlD
Propranolol—Bopindolol—ADRB3—type 2 diabetes mellitus	0.000223	0.0902	CrCbGaD
Propranolol—HTR1B—cardiovascular system—type 2 diabetes mellitus	0.000217	0.0227	CbGeAlD
Propranolol—ADRB1—cardiovascular system—type 2 diabetes mellitus	0.000204	0.0214	CbGeAlD
Propranolol—CYP3A7-CYP3A51P—liver—type 2 diabetes mellitus	0.000192	0.0201	CbGeAlD
Propranolol—Terbinafine—CYP11A1—type 2 diabetes mellitus	0.000191	0.0773	CrCbGaD
Propranolol—Carvedilol—HIF1A—type 2 diabetes mellitus	0.000185	0.0746	CrCbGaD
Propranolol—ADRB1—adipose tissue—type 2 diabetes mellitus	0.00018	0.0189	CbGeAlD
Propranolol—Alprenolol—ADRB3—type 2 diabetes mellitus	0.000178	0.0721	CrCbGaD
Propranolol—CYP3A5—islet of Langerhans—type 2 diabetes mellitus	0.000178	0.0186	CbGeAlD
Propranolol—HTR1A—cardiovascular system—type 2 diabetes mellitus	0.000175	0.0183	CbGeAlD
Propranolol—Pindolol—ADRB3—type 2 diabetes mellitus	0.000153	0.062	CrCbGaD
Propranolol—CYP3A5—nephron tubule—type 2 diabetes mellitus	0.000143	0.015	CbGeAlD
Propranolol—ORM1—liver—type 2 diabetes mellitus	0.000143	0.015	CbGeAlD
Propranolol—CYP1A1—kidney—type 2 diabetes mellitus	0.000129	0.0135	CbGeAlD
Propranolol—CYP3A5—kidney—type 2 diabetes mellitus	0.000126	0.0132	CbGeAlD
Propranolol—CYP3A5—pancreas—type 2 diabetes mellitus	0.000125	0.0131	CbGeAlD
Propranolol—CYP3A5—cortex of kidney—type 2 diabetes mellitus	0.000123	0.0128	CbGeAlD
Propranolol—CYP1A1—adipose tissue—type 2 diabetes mellitus	0.000116	0.0122	CbGeAlD
Propranolol—CYP3A5—adipose tissue—type 2 diabetes mellitus	0.000113	0.0119	CbGeAlD
Propranolol—Carvedilol—ADRB3—type 2 diabetes mellitus	0.00011	0.0445	CrCbGaD
Propranolol—Naphazoline—ADRA2A—type 2 diabetes mellitus	0.000101	0.0408	CrCbGaD
Propranolol—CYP2C19—liver—type 2 diabetes mellitus	0.000101	0.0106	CbGeAlD
Propranolol—ABCB1—islet of Langerhans—type 2 diabetes mellitus	9.44e-05	0.0099	CbGeAlD
Propranolol—CYP3A4—kidney—type 2 diabetes mellitus	9.44e-05	0.0099	CbGeAlD
Propranolol—CYP2D6—kidney—type 2 diabetes mellitus	9.29e-05	0.00974	CbGeAlD
Propranolol—CYP1A2—liver—type 2 diabetes mellitus	8.24e-05	0.00865	CbGeAlD
Propranolol—Erythema—Metformin—type 2 diabetes mellitus	8.14e-05	0.00104	CcSEcCtD
Propranolol—CYP1A1—liver—type 2 diabetes mellitus	8.13e-05	0.00853	CbGeAlD
Propranolol—Hypersensitivity—Pioglitazone—type 2 diabetes mellitus	8.11e-05	0.00104	CcSEcCtD
Propranolol—ABCB1—retina—type 2 diabetes mellitus	8.07e-05	0.00847	CbGeAlD
Propranolol—Vertigo—Valsartan—type 2 diabetes mellitus	8.03e-05	0.00103	CcSEcCtD
Propranolol—CYP3A5—liver—type 2 diabetes mellitus	7.95e-05	0.00834	CbGeAlD
Propranolol—Paraesthesia—Glyburide—type 2 diabetes mellitus	7.94e-05	0.00101	CcSEcCtD
Propranolol—Vertigo—Orlistat—type 2 diabetes mellitus	7.94e-05	0.00101	CcSEcCtD
Propranolol—Gastrointestinal pain—Bromocriptine—type 2 diabetes mellitus	7.91e-05	0.00101	CcSEcCtD
Propranolol—Hypersensitivity—Glimepiride—type 2 diabetes mellitus	7.9e-05	0.00101	CcSEcCtD
Propranolol—Asthenia—Pioglitazone—type 2 diabetes mellitus	7.9e-05	0.00101	CcSEcCtD
Propranolol—Infection—Gliclazide—type 2 diabetes mellitus	7.89e-05	0.00101	CcSEcCtD
Propranolol—Dyspnoea—Glyburide—type 2 diabetes mellitus	7.89e-05	0.00101	CcSEcCtD
Propranolol—Hypersensitivity—Sitagliptin—type 2 diabetes mellitus	7.88e-05	0.00101	CcSEcCtD
Propranolol—Stevens-Johnson syndrome—Ramipril—type 2 diabetes mellitus	7.87e-05	0.00101	CcSEcCtD
Propranolol—Diarrhoea—Glipizide—type 2 diabetes mellitus	7.86e-05	0.001	CcSEcCtD
Propranolol—Erythema multiforme—Losartan—type 2 diabetes mellitus	7.86e-05	0.001	CcSEcCtD
Propranolol—Cough—Valsartan—type 2 diabetes mellitus	7.8e-05	0.000997	CcSEcCtD
Propranolol—Nausea—Rosiglitazone—type 2 diabetes mellitus	7.8e-05	0.000996	CcSEcCtD
Propranolol—Nervous system disorder—Gliclazide—type 2 diabetes mellitus	7.79e-05	0.000995	CcSEcCtD
Propranolol—Dyspepsia—Glyburide—type 2 diabetes mellitus	7.79e-05	0.000995	CcSEcCtD
Propranolol—Skin disorder—Gliclazide—type 2 diabetes mellitus	7.72e-05	0.000986	CcSEcCtD
Propranolol—Cough—Orlistat—type 2 diabetes mellitus	7.71e-05	0.000985	CcSEcCtD
Propranolol—Asthenia—Glimepiride—type 2 diabetes mellitus	7.7e-05	0.000983	CcSEcCtD
Propranolol—Decreased appetite—Glyburide—type 2 diabetes mellitus	7.69e-05	0.000982	CcSEcCtD
Propranolol—Urticaria—Bromocriptine—type 2 diabetes mellitus	7.69e-05	0.000982	CcSEcCtD
Propranolol—Erythema—Irbesartan—type 2 diabetes mellitus	7.69e-05	0.000982	CcSEcCtD
Propranolol—Asthenia—Sitagliptin—type 2 diabetes mellitus	7.67e-05	0.00098	CcSEcCtD
Propranolol—Convulsion—Orlistat—type 2 diabetes mellitus	7.66e-05	0.000978	CcSEcCtD
Propranolol—Abdominal pain—Bromocriptine—type 2 diabetes mellitus	7.65e-05	0.000977	CcSEcCtD
Propranolol—Body temperature increased—Bromocriptine—type 2 diabetes mellitus	7.65e-05	0.000977	CcSEcCtD
Propranolol—Gastrointestinal disorder—Glyburide—type 2 diabetes mellitus	7.64e-05	0.000976	CcSEcCtD
Propranolol—ABCB1—nephron tubule—type 2 diabetes mellitus	7.6e-05	0.00797	CbGeAlD
Propranolol—Dizziness—Glipizide—type 2 diabetes mellitus	7.6e-05	0.000971	CcSEcCtD
Propranolol—Unspecified disorder of skin and subcutaneous tissue—Valsartan—type 2 diabetes mellitus	7.56e-05	0.000966	CcSEcCtD
Propranolol—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	7.53e-05	0.000963	CcSEcCtD
Propranolol—Unspecified disorder of skin and subcutaneous tissue—Orlistat—type 2 diabetes mellitus	7.47e-05	0.000954	CcSEcCtD
Propranolol—Carvedilol—VEGFA—type 2 diabetes mellitus	7.43e-05	0.03	CrCbGaD
Propranolol—Agranulocytosis—Ramipril—type 2 diabetes mellitus	7.41e-05	0.000946	CcSEcCtD
Propranolol—Alopecia—Losartan—type 2 diabetes mellitus	7.34e-05	0.000938	CcSEcCtD
Propranolol—Diarrhoea—Glimepiride—type 2 diabetes mellitus	7.34e-05	0.000938	CcSEcCtD
Propranolol—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	7.32e-05	0.000935	CcSEcCtD
Propranolol—Vomiting—Glipizide—type 2 diabetes mellitus	7.31e-05	0.000934	CcSEcCtD
Propranolol—Anaphylactic shock—Valsartan—type 2 diabetes mellitus	7.3e-05	0.000932	CcSEcCtD
Propranolol—Dizziness—Pioglitazone—type 2 diabetes mellitus	7.28e-05	0.00093	CcSEcCtD
Propranolol—Infection—Valsartan—type 2 diabetes mellitus	7.25e-05	0.000926	CcSEcCtD
Propranolol—Rash—Glipizide—type 2 diabetes mellitus	7.25e-05	0.000926	CcSEcCtD
Propranolol—Dermatitis—Glipizide—type 2 diabetes mellitus	7.24e-05	0.000925	CcSEcCtD
Propranolol—Gastrointestinal pain—Glyburide—type 2 diabetes mellitus	7.23e-05	0.000924	CcSEcCtD
Propranolol—Erythema—Losartan—type 2 diabetes mellitus	7.23e-05	0.000924	CcSEcCtD
Propranolol—Anaphylactic shock—Orlistat—type 2 diabetes mellitus	7.21e-05	0.000921	CcSEcCtD
Propranolol—Insomnia—Gliclazide—type 2 diabetes mellitus	7.18e-05	0.000918	CcSEcCtD
Propranolol—Infection—Orlistat—type 2 diabetes mellitus	7.16e-05	0.000915	CcSEcCtD
Propranolol—Nervous system disorder—Valsartan—type 2 diabetes mellitus	7.16e-05	0.000914	CcSEcCtD
Propranolol—Paraesthesia—Gliclazide—type 2 diabetes mellitus	7.13e-05	0.000911	CcSEcCtD
Propranolol—Dizziness—Glimepiride—type 2 diabetes mellitus	7.09e-05	0.000906	CcSEcCtD
Propranolol—Skin disorder—Valsartan—type 2 diabetes mellitus	7.09e-05	0.000906	CcSEcCtD
Propranolol—Dyspnoea—Gliclazide—type 2 diabetes mellitus	7.08e-05	0.000905	CcSEcCtD
Propranolol—Nervous system disorder—Orlistat—type 2 diabetes mellitus	7.07e-05	0.000903	CcSEcCtD
Propranolol—Dizziness—Sitagliptin—type 2 diabetes mellitus	7.07e-05	0.000903	CcSEcCtD
Propranolol—Agitation—Irbesartan—type 2 diabetes mellitus	7.06e-05	0.000902	CcSEcCtD
Propranolol—Somnolence—Gliclazide—type 2 diabetes mellitus	7.06e-05	0.000902	CcSEcCtD
Propranolol—Urticaria—Glyburide—type 2 diabetes mellitus	7.03e-05	0.000898	CcSEcCtD
Propranolol—Terbinafine—CYP1A2—type 2 diabetes mellitus	7.01e-05	0.0283	CrCbGaD
Propranolol—Duloxetine—HTR2C—type 2 diabetes mellitus	7.01e-05	0.0283	CrCbGaD
Propranolol—Skin disorder—Orlistat—type 2 diabetes mellitus	7e-05	0.000895	CcSEcCtD
Propranolol—Abdominal pain—Glyburide—type 2 diabetes mellitus	6.99e-05	0.000893	CcSEcCtD
Propranolol—Dyspepsia—Gliclazide—type 2 diabetes mellitus	6.99e-05	0.000893	CcSEcCtD
Propranolol—Asthenia—Bromocriptine—type 2 diabetes mellitus	6.94e-05	0.000887	CcSEcCtD
Propranolol—Vertigo—Irbesartan—type 2 diabetes mellitus	6.9e-05	0.000882	CcSEcCtD
Propranolol—Unspecified disorder of skin and subcutaneous tissue—Metformin—type 2 diabetes mellitus	6.89e-05	0.00088	CcSEcCtD
Propranolol—Visual impairment—Ramipril—type 2 diabetes mellitus	6.87e-05	0.000877	CcSEcCtD
Propranolol—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	6.86e-05	0.000876	CcSEcCtD
Propranolol—Fatigue—Gliclazide—type 2 diabetes mellitus	6.85e-05	0.000875	CcSEcCtD
Propranolol—ABCB1—cardiovascular system—type 2 diabetes mellitus	6.83e-05	0.00716	CbGeAlD
Propranolol—Nausea—Glipizide—type 2 diabetes mellitus	6.83e-05	0.000872	CcSEcCtD
Propranolol—Vomiting—Glimepiride—type 2 diabetes mellitus	6.82e-05	0.000871	CcSEcCtD
Propranolol—Vomiting—Sitagliptin—type 2 diabetes mellitus	6.8e-05	0.000869	CcSEcCtD
Propranolol—Constipation—Gliclazide—type 2 diabetes mellitus	6.79e-05	0.000868	CcSEcCtD
Propranolol—Pain—Gliclazide—type 2 diabetes mellitus	6.79e-05	0.000868	CcSEcCtD
Propranolol—Rash—Glimepiride—type 2 diabetes mellitus	6.76e-05	0.000864	CcSEcCtD
Propranolol—Dermatitis—Glimepiride—type 2 diabetes mellitus	6.76e-05	0.000863	CcSEcCtD
Propranolol—Betaxolol—CYP1A2—type 2 diabetes mellitus	6.75e-05	0.0273	CrCbGaD
Propranolol—Cinacalcet—CYP1A2—type 2 diabetes mellitus	6.75e-05	0.0273	CrCbGaD
Propranolol—Rash—Sitagliptin—type 2 diabetes mellitus	6.74e-05	0.000861	CcSEcCtD
Propranolol—Dermatitis—Sitagliptin—type 2 diabetes mellitus	6.74e-05	0.00086	CcSEcCtD
Propranolol—Erythema multiforme—Ramipril—type 2 diabetes mellitus	6.74e-05	0.00086	CcSEcCtD
Propranolol—Cough—Irbesartan—type 2 diabetes mellitus	6.71e-05	0.000857	CcSEcCtD
Propranolol—ABCB1—kidney—type 2 diabetes mellitus	6.68e-05	0.00701	CbGeAlD
Propranolol—Agitation—Losartan—type 2 diabetes mellitus	6.65e-05	0.000849	CcSEcCtD
Propranolol—ABCB1—pancreas—type 2 diabetes mellitus	6.64e-05	0.00696	CbGeAlD
Propranolol—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	6.62e-05	0.000846	CcSEcCtD
Propranolol—Infection—Metformin—type 2 diabetes mellitus	6.6e-05	0.000843	CcSEcCtD
Propranolol—Insomnia—Valsartan—type 2 diabetes mellitus	6.6e-05	0.000843	CcSEcCtD
Propranolol—Paraesthesia—Valsartan—type 2 diabetes mellitus	6.55e-05	0.000837	CcSEcCtD
Propranolol—Insomnia—Orlistat—type 2 diabetes mellitus	6.52e-05	0.000833	CcSEcCtD
Propranolol—Hypersensitivity—Glyburide—type 2 diabetes mellitus	6.52e-05	0.000833	CcSEcCtD
Propranolol—Nervous system disorder—Metformin—type 2 diabetes mellitus	6.52e-05	0.000833	CcSEcCtD
Propranolol—ABCB1—cortex of kidney—type 2 diabetes mellitus	6.51e-05	0.00683	CbGeAlD
Propranolol—Dyspnoea—Valsartan—type 2 diabetes mellitus	6.51e-05	0.000831	CcSEcCtD
Propranolol—Vertigo—Losartan—type 2 diabetes mellitus	6.5e-05	0.00083	CcSEcCtD
Propranolol—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	6.5e-05	0.00083	CcSEcCtD
Propranolol—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	6.5e-05	0.00083	CcSEcCtD
Propranolol—Somnolence—Valsartan—type 2 diabetes mellitus	6.49e-05	0.000829	CcSEcCtD
Propranolol—Paraesthesia—Orlistat—type 2 diabetes mellitus	6.48e-05	0.000827	CcSEcCtD
Propranolol—Skin disorder—Metformin—type 2 diabetes mellitus	6.46e-05	0.000825	CcSEcCtD
Propranolol—Dyspepsia—Valsartan—type 2 diabetes mellitus	6.42e-05	0.000821	CcSEcCtD
Propranolol—Dizziness—Bromocriptine—type 2 diabetes mellitus	6.4e-05	0.000817	CcSEcCtD
Propranolol—Nausea—Glimepiride—type 2 diabetes mellitus	6.37e-05	0.000814	CcSEcCtD
Propranolol—Nausea—Sitagliptin—type 2 diabetes mellitus	6.35e-05	0.000811	CcSEcCtD
Propranolol—Dyspepsia—Orlistat—type 2 diabetes mellitus	6.35e-05	0.000811	CcSEcCtD
Propranolol—Asthenia—Glyburide—type 2 diabetes mellitus	6.35e-05	0.000811	CcSEcCtD
Propranolol—Decreased appetite—Valsartan—type 2 diabetes mellitus	6.34e-05	0.00081	CcSEcCtD
Propranolol—Cough—Losartan—type 2 diabetes mellitus	6.31e-05	0.000806	CcSEcCtD
Propranolol—Urticaria—Gliclazide—type 2 diabetes mellitus	6.31e-05	0.000806	CcSEcCtD
Propranolol—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	6.3e-05	0.000805	CcSEcCtD
Propranolol—Alopecia—Ramipril—type 2 diabetes mellitus	6.3e-05	0.000804	CcSEcCtD
Propranolol—Fatigue—Valsartan—type 2 diabetes mellitus	6.29e-05	0.000804	CcSEcCtD
Propranolol—Abdominal pain—Gliclazide—type 2 diabetes mellitus	6.28e-05	0.000802	CcSEcCtD
Propranolol—Body temperature increased—Gliclazide—type 2 diabetes mellitus	6.28e-05	0.000802	CcSEcCtD
Propranolol—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	6.27e-05	0.000801	CcSEcCtD
Propranolol—Decreased appetite—Orlistat—type 2 diabetes mellitus	6.27e-05	0.000801	CcSEcCtD
Propranolol—Mental disorder—Ramipril—type 2 diabetes mellitus	6.24e-05	0.000797	CcSEcCtD
Propranolol—Constipation—Valsartan—type 2 diabetes mellitus	6.24e-05	0.000797	CcSEcCtD
Propranolol—Infection—Irbesartan—type 2 diabetes mellitus	6.23e-05	0.000796	CcSEcCtD
Propranolol—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	6.23e-05	0.000795	CcSEcCtD
Propranolol—Fatigue—Orlistat—type 2 diabetes mellitus	6.22e-05	0.000794	CcSEcCtD
Propranolol—Erythema—Ramipril—type 2 diabetes mellitus	6.2e-05	0.000792	CcSEcCtD
Propranolol—Pain—Orlistat—type 2 diabetes mellitus	6.17e-05	0.000788	CcSEcCtD
Propranolol—Vomiting—Bromocriptine—type 2 diabetes mellitus	6.15e-05	0.000786	CcSEcCtD
Propranolol—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	6.15e-05	0.000786	CcSEcCtD
Propranolol—Rash—Bromocriptine—type 2 diabetes mellitus	6.1e-05	0.000779	CcSEcCtD
Propranolol—Dermatitis—Bromocriptine—type 2 diabetes mellitus	6.1e-05	0.000779	CcSEcCtD
Propranolol—Skin disorder—Irbesartan—type 2 diabetes mellitus	6.09e-05	0.000778	CcSEcCtD
Propranolol—Diarrhoea—Glyburide—type 2 diabetes mellitus	6.05e-05	0.000773	CcSEcCtD
Propranolol—ABCB1—adipose tissue—type 2 diabetes mellitus	6.02e-05	0.00632	CbGeAlD
Propranolol—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	5.97e-05	0.000762	CcSEcCtD
Propranolol—Paraesthesia—Metformin—type 2 diabetes mellitus	5.97e-05	0.000762	CcSEcCtD
Propranolol—CYP3A4—liver—type 2 diabetes mellitus	5.97e-05	0.00626	CbGeAlD
Propranolol—Dyspnoea—Metformin—type 2 diabetes mellitus	5.93e-05	0.000757	CcSEcCtD
Propranolol—Somnolence—Metformin—type 2 diabetes mellitus	5.91e-05	0.000755	CcSEcCtD
Propranolol—Anaphylactic shock—Losartan—type 2 diabetes mellitus	5.9e-05	0.000754	CcSEcCtD
Propranolol—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	5.9e-05	0.000753	CcSEcCtD
Propranolol—CYP2D6—liver—type 2 diabetes mellitus	5.87e-05	0.00616	CbGeAlD
Propranolol—Infection—Losartan—type 2 diabetes mellitus	5.86e-05	0.000749	CcSEcCtD
Propranolol—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	5.85e-05	0.000748	CcSEcCtD
Propranolol—Dyspepsia—Metformin—type 2 diabetes mellitus	5.85e-05	0.000747	CcSEcCtD
Propranolol—Urticaria—Valsartan—type 2 diabetes mellitus	5.8e-05	0.000741	CcSEcCtD
Propranolol—Nervous system disorder—Losartan—type 2 diabetes mellitus	5.79e-05	0.000739	CcSEcCtD
Propranolol—Decreased appetite—Metformin—type 2 diabetes mellitus	5.78e-05	0.000738	CcSEcCtD
Propranolol—Abdominal pain—Valsartan—type 2 diabetes mellitus	5.77e-05	0.000737	CcSEcCtD
Propranolol—Nausea—Bromocriptine—type 2 diabetes mellitus	5.75e-05	0.000734	CcSEcCtD
Propranolol—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	5.74e-05	0.000733	CcSEcCtD
Propranolol—Fatigue—Metformin—type 2 diabetes mellitus	5.73e-05	0.000732	CcSEcCtD
Propranolol—Urticaria—Orlistat—type 2 diabetes mellitus	5.73e-05	0.000732	CcSEcCtD
Propranolol—Body temperature increased—Orlistat—type 2 diabetes mellitus	5.7e-05	0.000728	CcSEcCtD
Propranolol—Abdominal pain—Orlistat—type 2 diabetes mellitus	5.7e-05	0.000728	CcSEcCtD
Propranolol—Asthenia—Gliclazide—type 2 diabetes mellitus	5.7e-05	0.000728	CcSEcCtD
Propranolol—Agitation—Ramipril—type 2 diabetes mellitus	5.7e-05	0.000728	CcSEcCtD
Propranolol—Constipation—Metformin—type 2 diabetes mellitus	5.68e-05	0.000726	CcSEcCtD
Propranolol—Paraesthesia—Irbesartan—type 2 diabetes mellitus	5.63e-05	0.000719	CcSEcCtD
Propranolol—Vomiting—Glyburide—type 2 diabetes mellitus	5.62e-05	0.000719	CcSEcCtD
Propranolol—Dyspnoea—Irbesartan—type 2 diabetes mellitus	5.59e-05	0.000714	CcSEcCtD
Propranolol—Rash—Glyburide—type 2 diabetes mellitus	5.58e-05	0.000713	CcSEcCtD
Propranolol—Somnolence—Irbesartan—type 2 diabetes mellitus	5.58e-05	0.000712	CcSEcCtD
Propranolol—Dermatitis—Glyburide—type 2 diabetes mellitus	5.57e-05	0.000712	CcSEcCtD
Propranolol—Vertigo—Ramipril—type 2 diabetes mellitus	5.57e-05	0.000712	CcSEcCtD
Propranolol—Dyspepsia—Irbesartan—type 2 diabetes mellitus	5.52e-05	0.000705	CcSEcCtD
Propranolol—Decreased appetite—Irbesartan—type 2 diabetes mellitus	5.45e-05	0.000696	CcSEcCtD
Propranolol—Diarrhoea—Gliclazide—type 2 diabetes mellitus	5.44e-05	0.000694	CcSEcCtD
Propranolol—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	5.43e-05	0.000694	CcSEcCtD
Propranolol—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	5.41e-05	0.000692	CcSEcCtD
Propranolol—Cough—Ramipril—type 2 diabetes mellitus	5.41e-05	0.000691	CcSEcCtD
Propranolol—Fatigue—Irbesartan—type 2 diabetes mellitus	5.41e-05	0.000691	CcSEcCtD
Propranolol—Hypersensitivity—Valsartan—type 2 diabetes mellitus	5.38e-05	0.000687	CcSEcCtD
Propranolol—Convulsion—Ramipril—type 2 diabetes mellitus	5.37e-05	0.000686	CcSEcCtD
Propranolol—Pain—Irbesartan—type 2 diabetes mellitus	5.36e-05	0.000685	CcSEcCtD
Propranolol—Constipation—Irbesartan—type 2 diabetes mellitus	5.36e-05	0.000685	CcSEcCtD
Propranolol—Insomnia—Losartan—type 2 diabetes mellitus	5.34e-05	0.000682	CcSEcCtD
Propranolol—Hypersensitivity—Orlistat—type 2 diabetes mellitus	5.31e-05	0.000679	CcSEcCtD
Propranolol—Paraesthesia—Losartan—type 2 diabetes mellitus	5.3e-05	0.000677	CcSEcCtD
Propranolol—Duloxetine—CYP1A2—type 2 diabetes mellitus	5.29e-05	0.0214	CrCbGaD
Propranolol—Urticaria—Metformin—type 2 diabetes mellitus	5.28e-05	0.000674	CcSEcCtD
Propranolol—Dyspnoea—Losartan—type 2 diabetes mellitus	5.26e-05	0.000672	CcSEcCtD
Propranolol—Nausea—Glyburide—type 2 diabetes mellitus	5.25e-05	0.000671	CcSEcCtD
Propranolol—Abdominal pain—Metformin—type 2 diabetes mellitus	5.25e-05	0.000671	CcSEcCtD
Propranolol—Dizziness—Gliclazide—type 2 diabetes mellitus	5.25e-05	0.000671	CcSEcCtD
Propranolol—Somnolence—Losartan—type 2 diabetes mellitus	5.25e-05	0.00067	CcSEcCtD
Propranolol—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	5.24e-05	0.00067	CcSEcCtD
Propranolol—Asthenia—Valsartan—type 2 diabetes mellitus	5.24e-05	0.000669	CcSEcCtD
Propranolol—Dyspepsia—Losartan—type 2 diabetes mellitus	5.2e-05	0.000664	CcSEcCtD
Propranolol—Asthenia—Orlistat—type 2 diabetes mellitus	5.17e-05	0.000661	CcSEcCtD
Propranolol—Decreased appetite—Losartan—type 2 diabetes mellitus	5.13e-05	0.000655	CcSEcCtD
Propranolol—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	5.13e-05	0.000655	CcSEcCtD
Propranolol—Fatigue—Losartan—type 2 diabetes mellitus	5.09e-05	0.00065	CcSEcCtD
Propranolol—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	5.06e-05	0.000647	CcSEcCtD
Propranolol—Vomiting—Gliclazide—type 2 diabetes mellitus	5.05e-05	0.000645	CcSEcCtD
Propranolol—Pain—Losartan—type 2 diabetes mellitus	5.05e-05	0.000645	CcSEcCtD
Propranolol—Constipation—Losartan—type 2 diabetes mellitus	5.05e-05	0.000645	CcSEcCtD
Propranolol—Rash—Gliclazide—type 2 diabetes mellitus	5.01e-05	0.00064	CcSEcCtD
Propranolol—Dermatitis—Gliclazide—type 2 diabetes mellitus	5e-05	0.000639	CcSEcCtD
Propranolol—Diarrhoea—Valsartan—type 2 diabetes mellitus	4.99e-05	0.000638	CcSEcCtD
Propranolol—Urticaria—Irbesartan—type 2 diabetes mellitus	4.98e-05	0.000637	CcSEcCtD
Propranolol—Carvedilol—ADRA2A—type 2 diabetes mellitus	4.98e-05	0.0201	CrCbGaD
Propranolol—Nervous system disorder—Ramipril—type 2 diabetes mellitus	4.96e-05	0.000634	CcSEcCtD
Propranolol—Abdominal pain—Irbesartan—type 2 diabetes mellitus	4.96e-05	0.000633	CcSEcCtD
Propranolol—Body temperature increased—Irbesartan—type 2 diabetes mellitus	4.96e-05	0.000633	CcSEcCtD
Propranolol—Diarrhoea—Orlistat—type 2 diabetes mellitus	4.93e-05	0.00063	CcSEcCtD
Propranolol—Skin disorder—Ramipril—type 2 diabetes mellitus	4.92e-05	0.000628	CcSEcCtD
Propranolol—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	4.83e-05	0.000617	CcSEcCtD
Propranolol—Dizziness—Valsartan—type 2 diabetes mellitus	4.83e-05	0.000617	CcSEcCtD
Propranolol—Dizziness—Orlistat—type 2 diabetes mellitus	4.77e-05	0.000609	CcSEcCtD
Propranolol—Asthenia—Metformin—type 2 diabetes mellitus	4.77e-05	0.000609	CcSEcCtD
Propranolol—Nausea—Gliclazide—type 2 diabetes mellitus	4.72e-05	0.000603	CcSEcCtD
Propranolol—Urticaria—Losartan—type 2 diabetes mellitus	4.69e-05	0.000599	CcSEcCtD
Propranolol—Abdominal pain—Losartan—type 2 diabetes mellitus	4.67e-05	0.000596	CcSEcCtD
Propranolol—Body temperature increased—Losartan—type 2 diabetes mellitus	4.67e-05	0.000596	CcSEcCtD
Propranolol—Terbinafine—CYP3A4—type 2 diabetes mellitus	4.64e-05	0.0188	CrCbGaD
Propranolol—Ranolazine—CYP3A4—type 2 diabetes mellitus	4.64e-05	0.0188	CrCbGaD
Propranolol—Vomiting—Valsartan—type 2 diabetes mellitus	4.64e-05	0.000593	CcSEcCtD
Propranolol—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	4.62e-05	0.00059	CcSEcCtD
Propranolol—Rash—Valsartan—type 2 diabetes mellitus	4.6e-05	0.000588	CcSEcCtD
Propranolol—Dermatitis—Valsartan—type 2 diabetes mellitus	4.6e-05	0.000587	CcSEcCtD
Propranolol—Vomiting—Orlistat—type 2 diabetes mellitus	4.59e-05	0.000586	CcSEcCtD
Propranolol—Insomnia—Ramipril—type 2 diabetes mellitus	4.58e-05	0.000585	CcSEcCtD
Propranolol—Diarrhoea—Metformin—type 2 diabetes mellitus	4.55e-05	0.000581	CcSEcCtD
Propranolol—Rash—Orlistat—type 2 diabetes mellitus	4.55e-05	0.000581	CcSEcCtD
Propranolol—Paraesthesia—Ramipril—type 2 diabetes mellitus	4.54e-05	0.000581	CcSEcCtD
Propranolol—Dermatitis—Orlistat—type 2 diabetes mellitus	4.54e-05	0.00058	CcSEcCtD
Propranolol—Dyspnoea—Ramipril—type 2 diabetes mellitus	4.51e-05	0.000576	CcSEcCtD
Propranolol—Asthenia—Irbesartan—type 2 diabetes mellitus	4.5e-05	0.000575	CcSEcCtD
Propranolol—Somnolence—Ramipril—type 2 diabetes mellitus	4.5e-05	0.000575	CcSEcCtD
Propranolol—Cinacalcet—CYP3A4—type 2 diabetes mellitus	4.47e-05	0.0181	CrCbGaD
Propranolol—Dyspepsia—Ramipril—type 2 diabetes mellitus	4.46e-05	0.000569	CcSEcCtD
Propranolol—Decreased appetite—Ramipril—type 2 diabetes mellitus	4.4e-05	0.000562	CcSEcCtD
Propranolol—Dizziness—Metformin—type 2 diabetes mellitus	4.39e-05	0.000561	CcSEcCtD
Propranolol—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	4.37e-05	0.000558	CcSEcCtD
Propranolol—Fatigue—Ramipril—type 2 diabetes mellitus	4.36e-05	0.000557	CcSEcCtD
Propranolol—Hypersensitivity—Losartan—type 2 diabetes mellitus	4.35e-05	0.000556	CcSEcCtD
Propranolol—Nausea—Valsartan—type 2 diabetes mellitus	4.34e-05	0.000554	CcSEcCtD
Propranolol—Constipation—Ramipril—type 2 diabetes mellitus	4.33e-05	0.000553	CcSEcCtD
Propranolol—Bisoprolol—CYP3A4—type 2 diabetes mellitus	4.32e-05	0.0174	CrCbGaD
Propranolol—Diarrhoea—Irbesartan—type 2 diabetes mellitus	4.29e-05	0.000548	CcSEcCtD
Propranolol—Nausea—Orlistat—type 2 diabetes mellitus	4.28e-05	0.000547	CcSEcCtD
Propranolol—Asthenia—Losartan—type 2 diabetes mellitus	4.23e-05	0.000541	CcSEcCtD
Propranolol—Vomiting—Metformin—type 2 diabetes mellitus	4.23e-05	0.00054	CcSEcCtD
Propranolol—ABCB1—liver—type 2 diabetes mellitus	4.22e-05	0.00443	CbGeAlD
Propranolol—Rash—Metformin—type 2 diabetes mellitus	4.19e-05	0.000535	CcSEcCtD
Propranolol—Dermatitis—Metformin—type 2 diabetes mellitus	4.19e-05	0.000535	CcSEcCtD
Propranolol—Dizziness—Irbesartan—type 2 diabetes mellitus	4.15e-05	0.00053	CcSEcCtD
Propranolol—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	4.14e-05	0.000529	CcSEcCtD
Propranolol—Diarrhoea—Losartan—type 2 diabetes mellitus	4.04e-05	0.000516	CcSEcCtD
Propranolol—Urticaria—Ramipril—type 2 diabetes mellitus	4.02e-05	0.000514	CcSEcCtD
Propranolol—Body temperature increased—Ramipril—type 2 diabetes mellitus	4e-05	0.000511	CcSEcCtD
Propranolol—Abdominal pain—Ramipril—type 2 diabetes mellitus	4e-05	0.000511	CcSEcCtD
Propranolol—Vomiting—Irbesartan—type 2 diabetes mellitus	3.99e-05	0.000509	CcSEcCtD
Propranolol—Rash—Irbesartan—type 2 diabetes mellitus	3.95e-05	0.000505	CcSEcCtD
Propranolol—Dermatitis—Irbesartan—type 2 diabetes mellitus	3.95e-05	0.000505	CcSEcCtD
Propranolol—Nausea—Metformin—type 2 diabetes mellitus	3.95e-05	0.000504	CcSEcCtD
Propranolol—Dizziness—Losartan—type 2 diabetes mellitus	3.9e-05	0.000499	CcSEcCtD
Propranolol—Propafenone—CYP1A2—type 2 diabetes mellitus	3.84e-05	0.0155	CrCbGaD
Propranolol—Vomiting—Losartan—type 2 diabetes mellitus	3.75e-05	0.000479	CcSEcCtD
Propranolol—Hypersensitivity—Ramipril—type 2 diabetes mellitus	3.73e-05	0.000476	CcSEcCtD
Propranolol—Nausea—Irbesartan—type 2 diabetes mellitus	3.73e-05	0.000476	CcSEcCtD
Propranolol—Rash—Losartan—type 2 diabetes mellitus	3.72e-05	0.000475	CcSEcCtD
Propranolol—Dermatitis—Losartan—type 2 diabetes mellitus	3.72e-05	0.000475	CcSEcCtD
Propranolol—Atomoxetine—HTR2C—type 2 diabetes mellitus	3.67e-05	0.0148	CrCbGaD
Propranolol—Carvedilol—CYP2E1—type 2 diabetes mellitus	3.64e-05	0.0147	CrCbGaD
Propranolol—Asthenia—Ramipril—type 2 diabetes mellitus	3.63e-05	0.000464	CcSEcCtD
Propranolol—Nausea—Losartan—type 2 diabetes mellitus	3.51e-05	0.000448	CcSEcCtD
Propranolol—Diarrhoea—Ramipril—type 2 diabetes mellitus	3.46e-05	0.000442	CcSEcCtD
Propranolol—Carvedilol—CYP1A2—type 2 diabetes mellitus	3.46e-05	0.014	CrCbGaD
Propranolol—Dizziness—Ramipril—type 2 diabetes mellitus	3.35e-05	0.000428	CcSEcCtD
Propranolol—Vomiting—Ramipril—type 2 diabetes mellitus	3.22e-05	0.000411	CcSEcCtD
Propranolol—Rash—Ramipril—type 2 diabetes mellitus	3.19e-05	0.000408	CcSEcCtD
Propranolol—Dermatitis—Ramipril—type 2 diabetes mellitus	3.19e-05	0.000407	CcSEcCtD
Propranolol—Nausea—Ramipril—type 2 diabetes mellitus	3.01e-05	0.000384	CcSEcCtD
Propranolol—Propafenone—CYP3A4—type 2 diabetes mellitus	2.54e-05	0.0103	CrCbGaD
Propranolol—Carvedilol—CYP3A4—type 2 diabetes mellitus	2.29e-05	0.00926	CrCbGaD
Propranolol—Atomoxetine—CYP3A4—type 2 diabetes mellitus	1.83e-05	0.00741	CrCbGaD
Propranolol—CYP2C19—Metabolism—GNB3—type 2 diabetes mellitus	1.72e-06	3.82e-05	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.72e-06	3.82e-05	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.72e-06	3.82e-05	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—HMOX1—type 2 diabetes mellitus	1.72e-06	3.8e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—ADRA2A—type 2 diabetes mellitus	1.71e-06	3.79e-05	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—CALM1—type 2 diabetes mellitus	1.71e-06	3.78e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—IGF1—type 2 diabetes mellitus	1.71e-06	3.78e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—AKT2—type 2 diabetes mellitus	1.7e-06	3.78e-05	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—APOE—type 2 diabetes mellitus	1.7e-06	3.77e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling by GPCR—EGFR—type 2 diabetes mellitus	1.7e-06	3.76e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—CCL2—type 2 diabetes mellitus	1.7e-06	3.76e-05	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—PPARA—type 2 diabetes mellitus	1.69e-06	3.75e-05	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—CAT—type 2 diabetes mellitus	1.69e-06	3.75e-05	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.69e-06	3.75e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—INS—type 2 diabetes mellitus	1.69e-06	3.74e-05	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.68e-06	3.73e-05	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—GNB3—type 2 diabetes mellitus	1.68e-06	3.73e-05	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—APOA1—type 2 diabetes mellitus	1.68e-06	3.73e-05	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—HMOX1—type 2 diabetes mellitus	1.67e-06	3.71e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—IGF1—type 2 diabetes mellitus	1.67e-06	3.7e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—AKT2—type 2 diabetes mellitus	1.67e-06	3.7e-05	CbGpPWpGaD
Propranolol—HTR1B—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.66e-06	3.69e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling by GPCR—EGFR—type 2 diabetes mellitus	1.66e-06	3.68e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—CCL2—type 2 diabetes mellitus	1.66e-06	3.68e-05	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—CAT—type 2 diabetes mellitus	1.65e-06	3.66e-05	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.65e-06	3.66e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—CYP2E1—type 2 diabetes mellitus	1.64e-06	3.64e-05	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—APOB—type 2 diabetes mellitus	1.64e-06	3.64e-05	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—AGT—type 2 diabetes mellitus	1.64e-06	3.64e-05	CbGpPWpGaD
Propranolol—HTR1B—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.64e-06	3.63e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—IGF1—type 2 diabetes mellitus	1.63e-06	3.62e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—AKT2—type 2 diabetes mellitus	1.63e-06	3.62e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—SLC2A1—type 2 diabetes mellitus	1.63e-06	3.6e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling by GPCR—EGFR—type 2 diabetes mellitus	1.62e-06	3.6e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.62e-06	3.59e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	1.62e-06	3.59e-05	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—CALM1—type 2 diabetes mellitus	1.61e-06	3.58e-05	CbGpPWpGaD
Propranolol—CYP3A7—Metabolism—PTGS2—type 2 diabetes mellitus	1.61e-06	3.57e-05	CbGpPWpGaD
Propranolol—SLC22A2—Metabolism—PTGS2—type 2 diabetes mellitus	1.61e-06	3.57e-05	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—APOE—type 2 diabetes mellitus	1.61e-06	3.56e-05	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—APOB—type 2 diabetes mellitus	1.6e-06	3.56e-05	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—GSTM1—type 2 diabetes mellitus	1.6e-06	3.54e-05	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—APOA1—type 2 diabetes mellitus	1.59e-06	3.52e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	1.59e-06	3.52e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	1.59e-06	3.52e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—GNB3—type 2 diabetes mellitus	1.59e-06	3.51e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.59e-06	3.51e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.58e-06	3.51e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—CYP3A4—type 2 diabetes mellitus	1.58e-06	3.51e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—HMOX1—type 2 diabetes mellitus	1.58e-06	3.5e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	1.58e-06	3.5e-05	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—LPL—type 2 diabetes mellitus	1.57e-06	3.48e-05	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—GSTM1—type 2 diabetes mellitus	1.56e-06	3.46e-05	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.56e-06	3.45e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—SLC2A4—type 2 diabetes mellitus	1.56e-06	3.45e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—GCG—type 2 diabetes mellitus	1.56e-06	3.45e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—CAT—type 2 diabetes mellitus	1.56e-06	3.45e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	1.56e-06	3.45e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.55e-06	3.44e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.55e-06	3.43e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.55e-06	3.43e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	1.55e-06	3.43e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	1.55e-06	3.43e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	1.55e-06	3.43e-05	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.54e-06	3.42e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	1.54e-06	3.41e-05	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—ADCY5—type 2 diabetes mellitus	1.54e-06	3.41e-05	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—LPL—type 2 diabetes mellitus	1.53e-06	3.39e-05	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—GPX1—type 2 diabetes mellitus	1.53e-06	3.39e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.51e-06	3.35e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.51e-06	3.35e-05	CbGpPWpGaD
Propranolol—HTR1B—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.51e-06	3.35e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—APOB—type 2 diabetes mellitus	1.51e-06	3.35e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	1.51e-06	3.35e-05	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—ADCY5—type 2 diabetes mellitus	1.5e-06	3.32e-05	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—GPX1—type 2 diabetes mellitus	1.49e-06	3.31e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	1.49e-06	3.31e-05	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—CD36—type 2 diabetes mellitus	1.49e-06	3.3e-05	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—PPARG—type 2 diabetes mellitus	1.48e-06	3.28e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.48e-06	3.28e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.48e-06	3.28e-05	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—PPP2CA—type 2 diabetes mellitus	1.47e-06	3.26e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—GSTM1—type 2 diabetes mellitus	1.47e-06	3.26e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—RELA—type 2 diabetes mellitus	1.46e-06	3.23e-05	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—CD36—type 2 diabetes mellitus	1.46e-06	3.23e-05	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—INS—type 2 diabetes mellitus	1.45e-06	3.22e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—LPL—type 2 diabetes mellitus	1.44e-06	3.2e-05	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—PPP2CA—type 2 diabetes mellitus	1.44e-06	3.19e-05	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—SRC—type 2 diabetes mellitus	1.44e-06	3.18e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—RELA—type 2 diabetes mellitus	1.42e-06	3.16e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—ADCY5—type 2 diabetes mellitus	1.41e-06	3.13e-05	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—MTHFR—type 2 diabetes mellitus	1.41e-06	3.13e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—GPX1—type 2 diabetes mellitus	1.41e-06	3.12e-05	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—PPARG—type 2 diabetes mellitus	1.4e-06	3.1e-05	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.4e-06	3.1e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—RELA—type 2 diabetes mellitus	1.39e-06	3.09e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	1.39e-06	3.07e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	1.39e-06	3.07e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	1.39e-06	3.07e-05	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—PPARA—type 2 diabetes mellitus	1.39e-06	3.07e-05	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—MTHFR—type 2 diabetes mellitus	1.38e-06	3.06e-05	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—INS—type 2 diabetes mellitus	1.37e-06	3.04e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—CD36—type 2 diabetes mellitus	1.37e-06	3.04e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	1.36e-06	3.02e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—PPP2CA—type 2 diabetes mellitus	1.35e-06	3e-05	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—PPARA—type 2 diabetes mellitus	1.35e-06	3e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	1.35e-06	2.99e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—GNB3—type 2 diabetes mellitus	1.34e-06	2.98e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.34e-06	2.98e-05	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—AGT—type 2 diabetes mellitus	1.34e-06	2.98e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—HMOX1—type 2 diabetes mellitus	1.34e-06	2.96e-05	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—ALB—type 2 diabetes mellitus	1.33e-06	2.95e-05	CbGpPWpGaD
Propranolol—ADRB1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.33e-06	2.94e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	1.32e-06	2.93e-05	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—CALM1—type 2 diabetes mellitus	1.32e-06	2.93e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—CAT—type 2 diabetes mellitus	1.32e-06	2.92e-05	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—APOE—type 2 diabetes mellitus	1.32e-06	2.92e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.31e-06	2.91e-05	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—AGT—type 2 diabetes mellitus	1.31e-06	2.9e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.3e-06	2.89e-05	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—APOA1—type 2 diabetes mellitus	1.3e-06	2.88e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—MTHFR—type 2 diabetes mellitus	1.3e-06	2.88e-05	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—IL6—type 2 diabetes mellitus	1.3e-06	2.88e-05	CbGpPWpGaD
Propranolol—ADRB2—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.3e-06	2.87e-05	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—CALM1—type 2 diabetes mellitus	1.29e-06	2.86e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.28e-06	2.85e-05	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.28e-06	2.85e-05	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—APOE—type 2 diabetes mellitus	1.28e-06	2.85e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—APOB—type 2 diabetes mellitus	1.28e-06	2.84e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.28e-06	2.83e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—PPARA—type 2 diabetes mellitus	1.27e-06	2.83e-05	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—NOS3—type 2 diabetes mellitus	1.27e-06	2.83e-05	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—PIK3R1—type 2 diabetes mellitus	1.27e-06	2.83e-05	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—APOA1—type 2 diabetes mellitus	1.27e-06	2.81e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	1.27e-06	2.81e-05	CbGpPWpGaD
Propranolol—HTR1A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	1.27e-06	2.81e-05	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.26e-06	2.79e-05	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—ALB—type 2 diabetes mellitus	1.26e-06	2.79e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.26e-06	2.78e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	1.25e-06	2.78e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	1.25e-06	2.78e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling by GPCR—IL6—type 2 diabetes mellitus	1.25e-06	2.77e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—GSTM1—type 2 diabetes mellitus	1.25e-06	2.76e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.24e-06	2.75e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—AGT—type 2 diabetes mellitus	1.23e-06	2.74e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.23e-06	2.72e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—LPL—type 2 diabetes mellitus	1.22e-06	2.71e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.21e-06	2.69e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—CALM1—type 2 diabetes mellitus	1.21e-06	2.69e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—APOE—type 2 diabetes mellitus	1.21e-06	2.68e-05	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—NOS3—type 2 diabetes mellitus	1.2e-06	2.67e-05	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—PIK3R1—type 2 diabetes mellitus	1.2e-06	2.67e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.2e-06	2.67e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	1.2e-06	2.67e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	1.2e-06	2.67e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.2e-06	2.66e-05	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.2e-06	2.66e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—ADCY5—type 2 diabetes mellitus	1.2e-06	2.65e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—APOA1—type 2 diabetes mellitus	1.2e-06	2.65e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—GPX1—type 2 diabetes mellitus	1.19e-06	2.64e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.19e-06	2.63e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.18e-06	2.61e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.17e-06	2.6e-05	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—PTGS2—type 2 diabetes mellitus	1.17e-06	2.58e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—CD36—type 2 diabetes mellitus	1.16e-06	2.58e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	1.15e-06	2.55e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—PPP2CA—type 2 diabetes mellitus	1.15e-06	2.54e-05	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—PPARG—type 2 diabetes mellitus	1.15e-06	2.54e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—SRC—type 2 diabetes mellitus	1.14e-06	2.54e-05	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—INS—type 2 diabetes mellitus	1.12e-06	2.49e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—SRC—type 2 diabetes mellitus	1.12e-06	2.48e-05	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—PPARG—type 2 diabetes mellitus	1.12e-06	2.48e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.11e-06	2.47e-05	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—PTGS2—type 2 diabetes mellitus	1.1e-06	2.44e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—MTHFR—type 2 diabetes mellitus	1.1e-06	2.44e-05	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—INS—type 2 diabetes mellitus	1.1e-06	2.43e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—SRC—type 2 diabetes mellitus	1.09e-06	2.43e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.09e-06	2.42e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—PPARA—type 2 diabetes mellitus	1.08e-06	2.39e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.07e-06	2.36e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—PPARG—type 2 diabetes mellitus	1.05e-06	2.34e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—AGT—type 2 diabetes mellitus	1.05e-06	2.32e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.04e-06	2.3e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	1.04e-06	2.3e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—INS—type 2 diabetes mellitus	1.03e-06	2.29e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	1.03e-06	2.29e-05	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—ALB—type 2 diabetes mellitus	1.03e-06	2.28e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—CALM1—type 2 diabetes mellitus	1.03e-06	2.28e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—APOE—type 2 diabetes mellitus	1.02e-06	2.27e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.02e-06	2.27e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	1.02e-06	2.26e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—APOA1—type 2 diabetes mellitus	1.01e-06	2.25e-05	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—ALB—type 2 diabetes mellitus	1.01e-06	2.23e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—EGFR—type 2 diabetes mellitus	1e-06	2.22e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1e-06	2.22e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	9.88e-07	2.19e-05	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—PIK3R1—type 2 diabetes mellitus	9.85e-07	2.18e-05	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—NOS3—type 2 diabetes mellitus	9.85e-07	2.18e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—EGFR—type 2 diabetes mellitus	9.81e-07	2.17e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	9.78e-07	2.17e-05	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—IL6—type 2 diabetes mellitus	9.68e-07	2.15e-05	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—PIK3R1—type 2 diabetes mellitus	9.62e-07	2.13e-05	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—NOS3—type 2 diabetes mellitus	9.62e-07	2.13e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	9.61e-07	2.13e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—EGFR—type 2 diabetes mellitus	9.59e-07	2.13e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—ALB—type 2 diabetes mellitus	9.47e-07	2.1e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	9.44e-07	2.09e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	9.24e-07	2.05e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	9.21e-07	2.04e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—NOS3—type 2 diabetes mellitus	9.06e-07	2.01e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—PIK3R1—type 2 diabetes mellitus	9.06e-07	2.01e-05	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—PTGS2—type 2 diabetes mellitus	9.01e-07	2e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	8.97e-07	1.99e-05	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—AKT1—type 2 diabetes mellitus	8.93e-07	1.98e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—PPARG—type 2 diabetes mellitus	8.93e-07	1.98e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	8.85e-07	1.96e-05	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—PTGS2—type 2 diabetes mellitus	8.8e-07	1.95e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—INS—type 2 diabetes mellitus	8.75e-07	1.94e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	8.5e-07	1.88e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	8.33e-07	1.85e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—PTGS2—type 2 diabetes mellitus	8.29e-07	1.84e-05	CbGpPWpGaD
Propranolol—CYP3A7—Metabolism—AKT1—type 2 diabetes mellitus	8.1e-07	1.8e-05	CbGpPWpGaD
Propranolol—SLC22A2—Metabolism—AKT1—type 2 diabetes mellitus	8.09e-07	1.79e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	8.07e-07	1.79e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—ALB—type 2 diabetes mellitus	8.03e-07	1.78e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	7.94e-07	1.76e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	7.91e-07	1.75e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	7.82e-07	1.73e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—IL6—type 2 diabetes mellitus	7.71e-07	1.71e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—NOS3—type 2 diabetes mellitus	7.68e-07	1.7e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—PIK3R1—type 2 diabetes mellitus	7.68e-07	1.7e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—IL6—type 2 diabetes mellitus	7.54e-07	1.67e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—IL6—type 2 diabetes mellitus	7.37e-07	1.63e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—AKT1—type 2 diabetes mellitus	7.11e-07	1.58e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—PTGS2—type 2 diabetes mellitus	7.02e-07	1.56e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—AKT1—type 2 diabetes mellitus	6.96e-07	1.54e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	6.89e-07	1.53e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—AKT1—type 2 diabetes mellitus	6.8e-07	1.51e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	6.76e-07	1.5e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	6.19e-07	1.37e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	5.93e-07	1.31e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	5.93e-07	1.31e-05	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—AKT1—type 2 diabetes mellitus	5.86e-07	1.3e-05	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—AKT1—type 2 diabetes mellitus	5.53e-07	1.23e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	5.42e-07	1.2e-05	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—AKT1—type 2 diabetes mellitus	4.53e-07	1e-05	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—AKT1—type 2 diabetes mellitus	4.42e-07	9.8e-06	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—AKT1—type 2 diabetes mellitus	4.17e-07	9.23e-06	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—AKT1—type 2 diabetes mellitus	3.53e-07	7.82e-06	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	2.72e-07	6.04e-06	CbGpPWpGaD
